Trial
NCT02987010
Phase 2 Study of IDH305 in Low Grade Gliomas
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Glioma
Intervention
IDH305
Why stopped
Sponsor did not want to move forward with protocol; study was never opened.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-11